Inflammatory Bowel Disease Archives - Page 2 of 2

MH002 enters phase 2b: Can MRM Health’s live biotherapeutic consortium redefine ulcerative colitis treatment standards?

By Pallavi Madhiraju on January 10, 2026 Pharma & Biotech

MRM Health’s MH002 enters phase 2b for ulcerative colitis. Can this live biotherapeutic redefine immune-sparing treatment in IBD? Find out what’s at stake.

Enveda’s ENV-6946 enters Phase 1: Can a “multi-biologic in a pill” reshape the future of IBD therapy?

By Pallavi Madhiraju on January 1, 2026 Pharma & Biotech

Can Enveda’s ENV-6946 deliver the efficacy of biologics in a pill for IBD? Find out why its triple-cytokine Phase 1 trial is drawing industry attention.

« Previous 1 2